A Phase I Study of LFA102 in Japanese Patients

Clinical trial NCT01610050 · COMPLETED

Trial details

NCT number: NCT01610050
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Castration-resistant Prostate Cancer, Advanced Breast Cancer

Start date: 2012-06-01
Primary completion: 2014-02-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.